Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
As a component of the benzamidoxime prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Additionally we are shipping MARC2 Proteins (4) and and many more products for this protein.
Showing 10 out of 45 products:
Human Polyclonal MARC2 Primary Antibody for IHC, IHC (p) - ABIN4335312
Neve, Köfeler, Hendriks, Nordling, Gogvadze, Mkrtchian, Näslund, Ingelman-Sundberg: Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran. in PLoS ONE 2015
Show all 4 Pubmed References
Human Polyclonal MARC2 Primary Antibody for IHC, IHC (p) - ABIN4335313
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013
mARC2 has a pivotal role in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.
Functional characteristics of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians were determined.
human mARC-1 and mARC-2 are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor
Data indicate that mitochondrial amidoxime reducing components 1 and 2 together with the electron transport proteins NADH-cytochrome b5 reductase (CYB5R) and cytochrome b5 (CYB5) catalyze the reduction of N-hydroxylated compounds such as amidoximes.
Chlamydomonas reinhardtii ARC has a Zn-dependent activity and protein partners similar to human MARC1 and MARC2.
results provide the first hints that mARC might be involved in mitochondrial N(omega)-hydroxy-L-arginine reduction and could be of physiological significance in affecting endogenous nitric oxide levels.
analysis of the nature of ligands in the Mo(V) state of the active site of mARC-2
Arc1(MOSC-1) and Arc2(MOSC-2) proteins are monomeric in their active forms.
The presence of a novel reductive enzyme system of importance for lipid synthesis that is exclusively localized to the outer mitochondrial membrane and is composed of CYB5B, MOSC2, and a third unknown component (a CYB5B reductase).
As a component of the benzamidoxime prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively (By similarity).
MOCO sulphurase C-terminal domain containing 2
, MOSC domain-containing protein 2, mitochondrial
, moco sulfurase C-terminal domain-containing protein 2
, molybdenum cofactor sulfurase C-terminal domain-containing protein 2
, mitochondrial amidoxime reducing component 2